Total Raised

$600M

Investors Count

4

Funding, Valuation & Revenue

2 Fundings

Isomorphic Laboratories has raised $600M over 2 rounds.

Isomorphic Laboratories's latest funding round was a Series A for $600M on March 31, 2025.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

3/31/2025

Series A

$600M

$XXM

$X.XXB

((X.XXx))

FY XXXX

5

11/7/2021

Spinoff / Spinout

$XXM

0

FY undefined

10

Date

3/31/2025

11/7/2021

Round

Series A

Spinoff / Spinout

Amount

$600M

Investors

Valuation

$XXM

$XXM

Revenue

$X.XXB

((X.XXx))

FY XXXX

0

FY undefined

Sources

5

10

Start free trial
New call-to-action

Isomorphic Laboratories Investors

4 Investors

Isomorphic Laboratories has 4 investors. Alphabet invested in Isomorphic Laboratories's Series A funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

3/31/2025

3/31/2025

1
Series A

Holding Company

California

00/00/0000

00/00/0000

Google Ventures

Subscribe to see more

Corporate Venture

California

00/00/0000

00/00/0000

Thrive Capital

Subscribe to see more

Venture Capital

New York

00/00/0000

00/00/0000

Google DeepMind

Subscribe to see more

Corporation

United Kingdom

First funding

3/31/2025

00/00/0000

00/00/0000

00/00/0000

Last Funding

3/31/2025

00/00/0000

00/00/0000

00/00/0000

Investor

Google Ventures

Thrive Capital

Google DeepMind

Rounds

1
Series A

Subscribe to see more

Subscribe to see more

Subscribe to see more

Board Seats

Type

Holding Company

Corporate Venture

Venture Capital

Corporation

Location

California

California

New York

United Kingdom

New call-to-action

Compare Isomorphic Laboratories to Competitors

Cradle Logo
Cradle

Cradle focuses on protein engineering in the biotechnology sector, using machine learning to optimize protein sequences. It provides tools for designing improved variants of target proteins, integrating laboratory data, and predicting performance to support research and development. Its solutions are relevant for biotech teams working on various applications, including therapeutics, enzymes, vaccines, peptides, and antibodies. It was founded in 2021 and is based in Amsterdam, Netherlands.

Biomatter Logo
Biomatter

Biomatter is a synthetic biology company that focuses on creating new proteins for various applications within the health and sustainable manufacturing sectors. The company offers a proprietary intelligent architecture platform that develops proteins with the capabilities of traditional engineering methods. Biomatter was formerly known as Biomatter Designs. It was founded in 2018 and is based in Vilnius, Lithuania.

Insilico Medicine Logo
Insilico Medicine

Insilico Medicine focuses on artificial intelligence in drug discovery and development. The company provides artificial intelligence platforms for multi-omics target discovery, deep biology analysis, automated drug design, and predicting outcomes in clinical trials. The technologies are intended to assist in the process of discovering and developing new medications for various diseases. It was founded in 2014 and is based in New Territories, Hong Kong.

InstaDeep Logo
InstaDeep

InstaDeep focuses on delivering artificial intelligence (AI)-powered decision-making systems for various enterprise sectors. The company offers solutions that leverage computing, deep learning, and reinforcement learning to address challenges in industries such as biology, logistics, electronic design, and energy. Its products and services are designed to help the capabilities of businesses by providing advanced AI tools and research insights. InstaDeep was formerly known as Digital Ink Group. It was founded in 2014 and is based in London, United Kingdom.

Aqemia Logo
Aqemia

Aqemia focuses on transforming the drug discovery process. The company offers technology that combines quantum-inspired physics and machine learning to scale the drug discovery process, generating a rapidly growing pipeline of new drug candidates. It primarily sells to the pharmaceutical industry. It was founded in 2019 and is based in Paris, France.

Endel Logo
Endel

Endel specializes in creating personalized sound environments designed to reduce stress, improve sleep, and enhance productivity, utilizing neuroscience and circadian rhythm science. The company offers a range of products, including apps for iOS and Android, integrations with Alexa, and a standalone Apple Watch app, all featuring adaptive soundscapes that respond to real-time inputs such as time of day, weather, and heart rate. It was founded in 2018 and is based in Berlin, Germany.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.